Université Paris-Saclay, CNRS, Institut des Sciences Moléculaires d'Orsay, 91405 Orsay, France.
Université d'Orléans, CEMHTI UPR CNRS 3079, F-45071 Orléans, France.
Int J Pharm. 2020 Jul 30;585:119442. doi: 10.1016/j.ijpharm.2020.119442. Epub 2020 May 21.
Lansoprazole (LPZ) is an acid pump inhibitor, which readily degrades upon acidic or basic conditions and under heating. We investigated here LPZ stability upon incorporation in particles made of cyclodextrin metal-organic frameworks (CD-MOFs). LPZ loaded CD-MOFs were successfully synthesized, reaching high LPZ payloads of 23.2 ± 2.1 wt%, which correspond to a molar ratio of 1:1 between LPZ and γ-CD. The homogeneity of LPZ loaded CD-MOFs in terms of component distribution was confirmed by elemental mapping by STEM-EDX. Both CTAB, the surfactant used in the CD-MOFs synthesis, and LPZ compete for their inclusion in the CD cavities. CTAB allowed obtaining regular cubic particles of around 5 µm with 15 wt% residual CTAB amounts. When LPZ was incorporated, the residual CTAB amount was less than 0.1 wt%, suggesting a higher affinity of LPZ for the CDs than CTAB. These findings were confirmed by molecular simulations. Vibrational circular dichroism studies confirmed the LPZ incorporation inside the CDs. Solid-state NMR showed that LPZ was located in the CDs and that it remained intact even after three years storage. Remarkably, the CD-MOFs matrix protected the drug upon thermal decomposition. This study highlights the interest of CD-MOFs for the incorporation and protection of LPZ.
兰索拉唑(LPZ)是一种酸泵抑制剂,在酸性或碱性条件下以及加热时容易降解。我们在此研究了 LPZ 在由环糊精金属有机骨架(CD-MOF)制成的颗粒中掺入时的稳定性。成功合成了负载 LPZ 的 CD-MOF,达到了 23.2±2.1wt%的高 LPZ 载药量,这对应于 LPZ 和γ-CD 之间的摩尔比为 1:1。通过 STEM-EDX 元素映射证实了 LPZ 负载 CD-MOF 在组分分布方面的均匀性。用于 CD-MOF 合成的表面活性剂 CTAB 和 LPZ 竞争其包含在 CD 腔中。CTAB 允许获得约 5 µm 的规则立方颗粒,残留 CTAB 量为 15wt%。当掺入 LPZ 时,残留的 CTAB 量小于 0.1wt%,表明 LPZ 对 CD 的亲和力高于 CTAB。这些发现得到了分子模拟的证实。振动圆二色性研究证实了 LPZ 掺入 CD 内部。固态 NMR 表明 LPZ 位于 CD 中,即使在三年储存后仍保持完整。值得注意的是,CD-MOF 基质在热分解时保护了药物。这项研究强调了 CD-MOF 用于掺入和保护 LPZ 的兴趣。